Android app Apple app link

Korro secures approvals in Australia to commence AATD trial of KRRO-110

By Yahoo! Finance   |   3 months ago
Korro secures approvals in Australia to commence AATD trial of KRRO-110

Korro Bio has received approvals in Australia to start the Phase I/IIa REWRITE trial for KRRO-110, targeting alpha-1 antitrypsin deficiency.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.